stockrowMedpace Holdings, Inc.
MEDP Healthcare Diagnostics & Research
Medpace Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.5 billion, up 20.0% from fiscal 2024.
- Revenue
- +8.50%
- EPS
- +24.6%
- Free cash flow
- −16.6%
Quarter to September 2026, against a year earlier
Follow MEDP
Alert me
Medpace Holdings, Inc. (MEDP) Revenue growth
Medpace Holdings, Inc.'s revenue growth over the twelve months to 30 September 2026 was 20.4%, up 0.4 percentage points from fiscal 2025 (20.0%). Over the past ten years it has ranged from 3.46% (fiscal 2017) to 61.6% (fiscal 2018); the current reading is higher than 55% of that period. That is above the Diagnostics & Research industry median of 8.99% and above the Healthcare sector median of 7.80%.
Revenue growth, annual
Embed this chart
Annual newest first
| Period | Revenue growth | Change (points) |
|---|---|---|
| FY2025 | 20.0% | 8.13 |
| FY2024 | 11.8% | (17.33) |
| FY2023 | 29.2% | 1.37 |
| FY2022 | 27.8% | 4.42 |
| FY2021 | 23.4% | 15.84 |
| FY2020 | 7.54% | (14.65) |
| FY2019 | 22.2% | (39.36) |
| FY2018 | 61.6% | 58.09 |
| FY2017 | 3.46% | (13.95) |
| FY2016 | 17.4% | 7.41 |
Quarterly newest first
| Period | Revenue growth | Change (points) |
|---|---|---|
| Sep 2026 | 8.50% | (8.74) |
| Jun 2026 | 17.2% | (9.26) |
| Mar 2026 | 26.5% | (5.53) |
| Dec 2025 | 32.0% | 8.29 |
| 40 more quarters | Free account |
Against its own ten years
Revenue growth against peers
| Company | Revenue growth |
|---|---|
| GH Guardant Health, Inc. compare | 41.7% |
| MEDP Medpace Holdings, Inc. | 20.4% |
| DGX Quest Diagnostics Incorporated compare | 9.13% |
| LH Labcorp Holdings Inc. compare | 6.02% |
| ILMN Illumina, Inc. compare | 5.83% |
| RVTY Revvity Inc. compare | 4.56% |
| QGEN QIAGEN N.V. compare | 2.96% |
| ICLR ICON PLC compare | 1.82% |
| CRL Charles River Laboratories International, Inc. compare | −1.16% |
| Diagnostics & Research industry median | 8.99% |
| Healthcare sector median | 7.80% |
| Market median | 7.58% |
What Revenue growth is
Revenue Growth shows how fast a company’s sales are rising or falling compared with the same period a year earlier.
(Revenue − Revenue a year earlier) ÷ |Revenue a year earlier|
More on MEDP
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement